Seres Therapeutics and Nestlé Health Science have teamed up for the joint commercialization of Seres’ investigational oral microbiome treatment for recurrent Clostridioides difficile (C. difficile) infections.
Ashfield Engage, part of UDG Healthcare plc, today announced that it has been selected by U.S.-based Pacira BioSciences Inc. to provide strategic commercialization services for the company’s non-opioid pain management products in select European countries. Pacira has partnered with Ashfield Engage to develop a commercial strategy and deliver outsourced operations in numerous European countries, including the UK, Germany, Sweden, Austria, the Netherlands and Finland.
Fingerpaint, a full-service health and wellness marketing agency, executed a strategic investment in Leaderboard Branding, a leading global naming and branding business headquartered in Charlotte, N.C., to grow its portfolio of companies.
MacroGenics Inc. announced a partnership with Eversana to commercialize margetuximab in the United States, if approved.